Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma

Fig. 1

A: The Kaplan Meier analysis demonstrated significant differences between the effusion group and control group for lymphoma patients in EFS (p < 0.01). The hazard ratio was 0.191 for EFS. A: The Kaplan Meier analysis demonstrated significant differences between the effusion group and control group for lymphoma patients in OS (p < 0.01). The hazard ratio was 0.161 for OS

Back to article page